A groundbreaking study has mapped 50,000 mysterious DNA 'knots' in the human genome, revealing potential new avenues for disease diagnosis and...

In a promising new development, scientists have uncovered how the body’s natural killer cells, a crucial part of our immune system, can recognize...

Researchers at UC San Francisco have developed a groundbreaking approach to treating Parkinson’s disease with a new type of brain implant called...

Researchers at UC San Francisco have developed a groundbreaking approach to treating Parkinson’s disease with a new type of brain implant called...

Thanks to an experiment started before the Great Depression, researchers have pinpointed the genes behind the remarkable adaptability of barley, a...

Mpox, a viral illness first identified in Africa in 1970, made headlines in 2022 when it spread across the globe for the first time. Since then, the...

Mpox, a viral illness first identified in Africa in 1970, made headlines in 2022 when it spread across the globe for the first time. Since then, the...

The FDA removes the partial clinical holds on Rezolute's phase III study evaluating RZ358 for treating congenital hyperinsulinism.

The FDA removes the partial clinical holds on Rezolute's phase III study evaluating RZ358 for treating congenital hyperinsulinism.

RXRX plummets on mixed results from the mid-stage study of its lead candidate, REC-994, for treating a rare neurovascular condition.